ABVC BIOPHARMA, INC.
New Form D on file · 2026-11-10 · the record
Before you sell to, join or invest in ABVC BIOPHARMA, INC.
MentionFox check on ABVC BIOPHARMA, INC.: only 1 source on file so far (checked 13 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/abvc-biopharma-inc-form-d-118072
Check ABVC BIOPHARMA, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
ABVC BIOPHARMA, INC. filed a Form D with the Securities and Exchange Commission on 2026-11-10.
ABVC BIOPHARMA, INC. filed a Form D notice of an exempt securities offering with the SEC on November 10, 2026. The filing reports $3.39M sold. Its industry group is Biotechnology. It names Uttam Patil (Executive Officer), Eugene Jiang (Executive Officer, Director), Tsung-Shann Jiang (Executive Officer, Director) (SEC Form D, November 10, 2026).
Sell to companies like ABVC BIOPHARMA, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
ABVC BIOPHARMA, INC. raised on Nov 10. 88 companies raised this week, 1 had other signals.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| fal - Features & Labels, Inc. | $1B | AI and software |
| fal - Features & Labels, Inc. | $350M | AI and software |
| SIERRA INTERNATIONAL NETWORK INC | $300M | AI and software |
| Zai Lab Ltd | $250M | Biotech |
| Databento Inc. | $100M | AI and software |
Selling to Abvc Biopharma, Inc.? See who runs it and how to reach them, plus this week's 84 other newly funded companies.
Is this your company?
New Form D on file · 2026-11-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ABVC BIOPHARMA, INC.
Free to see. No signup.
Get an email when ABVC BIOPHARMA, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ABVC BIOPHARMA, INC. raises, hires or launches. No email unless you switch it on.
Watch ABVC BIOPHARMA, INC. →Get the full cited report on ABVC BIOPHARMA, INC.
What the filing shows about ABVC BIOPHARMA, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on ABVC BIOPHARMA, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look ABVC BIOPHARMA, INC. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on ABVC BIOPHARMA, INC.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives ABVC BIOPHARMA, INC.'s address as 44370 Old Warm Springs Blvd, Fremont, CA 94538.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for ABVC BIOPHARMA, INC. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
ABVC BIOPHARMA, INC. is a registered filer with the SEC (CIK 1173313) and has filed since 2023-03-02. 3 filings are on record, the latest on 2026-11-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ABVC BIOPHARMA, INC.'s Form D of 2026-11-10 names Uttam Patil, Eugene Jiang, Tsung-Shann Jiang and 9 more as its officers, directors or promoters.
Its new offerings report $7.31M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 757 filings in Biotechnology, totalled by week. The dot is this raise, $3.39M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Uttam Patil is named as Executive Officer on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Eugene Jiang is named as Executive Officer and Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Tsung-Shann Jiang is named as Executive Officer and Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Tsang Ming Jiang is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Chang-Jen Jiang is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Norimi Sakamoto is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Yen-Hsin Chou is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Hsin-Hui Miao is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Yoshinobu Odaira is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Che-Wei Hsu is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Shuling Jiang is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
Yu-Min (Francis) Chung is named as Director on the Form D that ABVC BIOPHARMA, INC. filed with the SEC on 10 November 2026, one of 12 people that filing names.
12 people named on the filing — 3 holding an executive role and 9 as directors only.
Named as of the 2026-11-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about ABVC BIOPHARMA, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on ABVC BIOPHARMA, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ABVC BIOPHARMA, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
12 people named on this filing See who they are
Start a free 5-day trial →You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ABVC BIOPHARMA, INC.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for ABVC BIOPHARMA, INC.. With no account yet, you sign up free and land on the result.
On these lists: San Francisco Bay Area raises, week of 2026-11-09 · Biotech raises, week of 2026-11-09 · Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/abvc-biopharma-inc-form-d-118072